Image of 2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conferenc
Digital Seminar

2-Day Alzheimer’s Disease and Other Neurocognitive Disorders Conference: Update on Risks, Treatment and Evidence-Based Management of Complex Issues


Faculty:
M. Catherine Wollman
Duration:
2 Full Days
Copyright :
Dec 09, 2019
Product Code:
POS078020
Media Type:
Digital Seminar


Description

Alzheimer’s disease and other neurocognitive disorders are disabling health conditions that create daunting challenges to patients, families and clinicians.

Are you prepared to manage and anticipate the complex patient needs that emerge when caring for these patients?

Have there been times in the past that you wished you had done more…?

Catherine Wollman, DNP, CRNP, GNP-BC, will provide the very latest research about who’s at risk, what’s at stake, and what we can realistically do to manage the impact of neurocognitive disorders.

Knowledge and evidence in dementia care are constantly changing. We will focus on the newest science, but also the use of ingenuity and compassion to address the multiple problems facing patients and families.

Unique clinical challenges will be reviewed using personal stories and case studies to decide the best pharmacological and non-pharmacological interventions to transform your own practice.

Alzheimer’s disease and other neurocognitive disorders will touch almost all of us personally or professionally.

During this intense recording, Catherine will provide you with new clinical insights and critical thinking skills so that you won’t need to feel uncertain, frustrated or at risk anymore!

Credits


CE Information Coming Soon

Continuing education credit information is coming soon for this non-interactive self-study package.

CEs may be available for select professions, as listed in the target audience. Hours will be dependent on the actual recording time. Please check with your state licensing board or organization for specific requirements. 

There may be an additional fee for CE certificates. Please contact our Customer Service at 1-800-844-8260 for more details. 

**Materials that are included in this course may include interventions and modalities that are beyond the authorized practice of mental health professionals. As a licensed professional, you are responsible for reviewing the scope of practice, including activities that are defined in law as beyond the boundaries of practice in accordance with and in compliance with your professions standards.



Faculty

M. Catherine Wollman Related seminars and products: 3

DNP, CRNP, GNP-BC


M. Catherine Wollman, DNP, CRNP, GNP-BC, has been a gerontological nurse practitioner for over 30 years, caring for older adults in acute care, long-term care and home care. Catherine currently provides geriatric consultation services. Her expertise is often sought for the care of particularly challenging dementia cases.

She worked as the director of senior health for a large hospital system offering a full spectrum of services, including comprehensive interdisciplinary dementia care. Catherine has travelled the country, offering her clinical expertise through various trainings to experienced healthcare audiences. Additionally, she has published articles and book chapters about relevant issues affecting older adults.

Speaker Disclosures:

Financial: M. Catherine Wollman is a visiting professor with Chamberlain College of Nursing. She receives a speaking honorarium from PESI, Inc.

Non-financial: M. Catherine Wollman is a member of the Gerontological Advanced Practice Nurses Association.


Additional Info

Program Information

CD/DVD

Click here to purchase the DVD or CD recording from our product store. CE hours and approvals on products may differ from live CE approvals.


Additional Resources

To order the book, Psychopharmacology, 3rd Edition, please visit our product store.

To order the book, Reflect, please visit our product store.


Access for Self-Study (Non-Interactive)

Access never expires for this product.


Objectives

  1. Differentiate cognitive impairment, dementias, neurocognitive disorders and their unique symptoms and trajectories.
  2. Review new DSM5™ changes and updated research on neurocognitive disorders.
  3. Evaluate the current status of dementia research, including new risks, causes and prevention of Alzheimer’s disease.
  4. Summarize screening tools and diagnostic methods for neurocognitive disorders.
  5. Recognize the impact of neurocognitive disorders/ dementias on the individual, family, caregivers and healthcare providers.
  6. Develop a comprehensive interdisciplinary plan of care for the patient and family with neurocognitive disorders/ dementias.
  7. Synthesize evidence-based interventions for behavioral and psychological symptoms of dementia.
  8. Discuss pharmacologic therapy for neurocognitive disorders/ dementias, delirium and depression.
  9. Summarize clinical updates on delirium from prevention and early recognition to effective management.
  10. Examine ethical issues related to neurocognitive disorders including capacity, safety, diagnosis disclosure, palliative and end of life care.
  11. Improve quality of life and outcomes of care for patients and families with neurocognitive disorders/ dementias.
  12. Analyze case studies of complex patients with neurocognitive disorders/ dementias.

Outline

Neurocognitive Disorders, Dementia and Cognitive Impairment

  • DSM-5™ changes and terminology
  • Aging and neurodegeneration
  • New research related to pathophysiology, diagnosis, risk factors and prevention

Differentiate Neurodegenerative Disorders

  • Alzheimer’s disease
  • Vascular disease
  • Frontotemporal disorder
  • Lewy body disease
  • Traumatic Brain Injury

Update on Delirium

  • Acute or persistent delirium
  • Screening and diagnosis
  • Prevent life threatening consequences
  • Evidence-based medications and treatment
  • Long term consequences

Diagnosis of Neurocognitive Disorders/Dementias

  • Reversible dementia-like disorders and conditions
  • Validated cognitive screening tools
  • New diagnostic criteria and stages of dementia
  • Family response to diagnosis

Pharmacologic Therapies for Neurocognitive Disorders/Dementias

  • Cholinesterase inhibitors
  • NMDA receptor antagonists
  • Antidepressants
  • Antipsychotics and other psychotropic drugs
  • Evaluate new drugs and learn medications to avoid
  • Consider risk, side effects, and efficacy for older adults

Behavioral and Psychological Symptoms of Dementia (BPSD)

  • Vast majority of patients with one or more BPSD
  • Serious negative consequences of untreated behaviors
  • Tools to systematically assess the presence and severity of symptoms
  • Investigation of multiple contributing factors
  • Interdisciplinary creation and evaluation of a treatment plan

Interventions for Common Distressing Behaviors

  • Agitation, anxiety and restlessness that lead to emotional distress and disability
  • Apathy that contributes to poor prognosis and increased mortality
  • Sexually inappropriate behaviors – one of the most distressing behaviors
  • Frustration of changing behaviors over time

Best Practice for Unique Challenges

  • Eliminate pain-inducing factors to diminish behaviors
  • Nutrition and hydration challenges with disease progression
  • Sleep disorders and evidencebased management
  • Depression and effective therapy
  • Psychotic symptoms: Nonpharmacological and pharmacological interventions

Ethical Issues

  • Safety, function and autonomy
  • Comfort and dignity
  • Advance care planning
  • Palliative care and hospice
  • Genetic testing
  • Disclosure of diagnosis

Patient/Family Needs Across the Disease Trajectory

  • Professional and family caregivers
  • Community Resources

Case Studies and Clinical Stories

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • PTs and PTAs
  • OTs and OTAs
  • SLPs
  • Social Workers
  • Nursing Home Administrators
  • Mental Health Professionals from Hospitals
  • Skilled Nursing Facilities
  • Clinics
  • Assisted Living Facilities
  • Anyone desiring next-level skills to proactively assess and intervene for patients with neurocognitive disorders!

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs

We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

Please wait ...

Back to Top